Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Lifestyle Intervention Program for Women With Gestational Diabetes or Gestational Impaired Glucose Tolerance (APPLES)

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
Kaiser Permanente Identifier:
First received: December 7, 2011
Last updated: July 26, 2016
Last verified: July 2016
The purpose of this research study is to implement and evaluate a lifestyle program designed to help women who have high glucose levels during pregnancy make healthful diet and physical activity changes to lose weight. Eligible women will be randomly assigned to life-style intervention or usual medical care.

Condition Intervention
Gestational Diabetes
Behavioral: Lifestyle Counseling

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Translational Diabetes Prevention in GDM

Further study details as provided by Kaiser Permanente:

Primary Outcome Measures:
  • postpartum body weight [ Time Frame: through 24 months postpartum ]

Secondary Outcome Measures:
  • the proportion of women who reach body weight goals [ Time Frame: through 24 months postpartum ]
  • percent of calories from fat [ Time Frame: through 24 months postpartum ]
  • time spent in physical activity (PA) by intensity [ Time Frame: through 24 months postpartum ]
  • postpartum glycemia [ Time Frame: through 24 months postpartum ]

Estimated Enrollment: 350
Study Start Date: December 2011
Primary Completion Date: October 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lifestyle Counseling Behavioral: Lifestyle Counseling
The Phase I intervention will be delivered through 1 individual in-person session and 3 individual telephone counseling contacts. The Phase II intervention begins at 6-week postpartum and will be delivered through 3 individual in-person sessions and 13 telephone counseling contacts over a period of 6 months. The maintenance phase (Phase III) will begin at 8 months postpartum.
No Intervention: Control


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Women receiving prenatal care at Kaiser Permanente Santa Clara, Santa Teresa, Hayward, and Oakland
  • Pregnancy complicated by high glucose levels starting November 2011

Exclusion Criteria:

  • Recognized DM prior to pregnancy
  • Uncontrolled hypertension during pregnancy
  • Severe active thyroid disease during pregnancy
  • Severe diseases of the cardio-pulmonary system
  • Diagnosis of a severe psychiatric disorder
  • Diagnosis of cancer
  • Conditions that lead to diet changes
  • Addiction to alcohol or illegal drugs
  • Current corticosteroid medicine use
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01489163

United States, California
Division of Research Northern California
Oakland, California, United States, 94612
Sponsors and Collaborators
Kaiser Permanente
Principal Investigator: Assiamira Ferrara, MD, PhD Kaiser Permanente Division of Research
  More Information

Additional Information:
Responsible Party: Kaiser Permanente Identifier: NCT01489163     History of Changes
Other Study ID Numbers: CN-03AFerr-02-H
Study First Received: December 7, 2011
Last Updated: July 26, 2016

Keywords provided by Kaiser Permanente:
Gestational Diabetes
Weight Loss
Physical Activity

Additional relevant MeSH terms:
Diabetes Mellitus
Diabetes, Gestational
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Pregnancy Complications processed this record on April 28, 2017